News

Filter

Current filters:

pomalidomideResearch

Celgene's pomalidomide meets primary endpoint in multiple myeloma

05-09-2013

US biotech major Celgene (Nasdaq: CELG) announced that positive updated results from MM-003, a Phase…

BiotechnologyCelgeneImnovidOncologypomalidomidePomalystResearch

Celgene's pomalidomide meets MM-003 study endpoints

23-10-2012

US biotech firm Celgene's (Nasdaq: CELG) European subsidiary yesterday revealed that its phase III, multi-center,…

BiotechnologyCelgeneOncologypomalidomideResearch

COMPANY SPOTLIGHT

Menarini

Back to top